biata medication for diabetes
Byetta and Bydureon are injectable drug pens used to control blood sugar in people with Type 2 diabetes. They are linked to pancreatitis and pancreatic cancer, which have led to lawsuits. Byetta (exenatide injection) is a twice-daily injectable drug approved by the U.S. Food and Drug Administration (FDA) for the treatment of Type 2 diabetes. The drug is designed to work with diet and exercise to control blood sugar. Manufactured by San Diego-based Amylin Pharmaceuticals, Byetta was approved by the FDA in 2005.